Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Abraxis BioScience
Woman Max 99 years
Abraxis BioScience, LLC, a wholly-owned subsidiary of Celgene Corporation
Update Il y a 4 ans
Clinical study for patients with breast cancer that has spread to other parts of the body and that does not respond to hormonal or anti-HER2 therapy ('triple negative disease'), comparing a chemotherapy treatment (carboplatin + gemcitabine) with an experimental treatment of nab-paclitaxel plus chemotherapy (carboplatin OR gemcitabine)
- Phase 2: evaluate the benefit and risk profiles of the two nab-paclitaxel experimental arms and identify the nab-paclitaxel combination that will be used in the Phase 3. - Phase 3: compare the p...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Abraxis BioScience, LLC, a wholly-owned subsidiary of Celgene Corporation
Update Il y a 4 ans
A clinical trial to compare the safety and effectiveness of Abraxane versus dacarbazine, in the treatment of advanced stage melanoma that has spread to other parts of the body (metastatic malignant melanoma)
The primary objective of this study is to compare the following regimens with respect to antitumor activity in patients who are previously untreated with cytotoxic chemotherapy for metastatic malignan...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Abraxis BioScience
Update Il y a 4 ans
Essai de phase 3 randomisé comparant l’efficacité et la tolérance de l’ABI-007 à la dacarbazine, chez des patients ayant un mélanome métastatique. [essai clos aux inclusions]
L’objectif de cet essai est de comparer l’efficacité et la tolérance de l’ABI-007 à la dacarbazine, chez des patients ayant un mélanome métastatique. Les patients seront répartis de façon aléatoire e...
Country
France
organs
Mélanomes cutanés
Specialty
Chimiothérapie
Essai clos aux inclusions
More information